Elevated serum prolactin levels as a marker of inflammatory arthritis in psoriasis vulgaris
Jazyk angličtina Země Česko Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
26175050
DOI
10.5507/bp.2015.033
Knihovny.cz E-zdroje
- Klíčová slova
- arthritis, immune cells, prolactin, psoriasis vulgaris, psoriatic arthritis, serum levels,
- MeSH
- biologické markery metabolismus MeSH
- dospělí MeSH
- imunoradiometrická analýza MeSH
- lidé MeSH
- prolaktin metabolismus MeSH
- psoriatická artritida diagnóza MeSH
- psoriáza diagnóza MeSH
- studie případů a kontrol MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- biologické markery MeSH
- prolaktin MeSH
BACKGROUND AND AIMS: Psoriasis vulgaris (PV) is complicated in up to 40% patients by the inflammatory joint disease psoriatic arthritis (PsA). Neither the aetiology of the arthritis nor specific laboratory markers for its disease activity have been clearly elucidated. Prolactin (PRL) acts as a cytokine with immunomodulatory functions and plays a role in skin and joint biology. The results on PRL however as a marker are unclear. The aim of this study was to confirm whether serum PRL levels reflect systemic complications of PV, like inflammatory joint disease and/or can serve as a marker of disease activity in both cases. METHODS: A total of 70 patients with PV without arthritis and 40 patients suffering from PsA were included. In all patients, we determined skin disease activity according to the PASI index and in PsA, active disease assessed as swollen or tender joints. The control group included 27 age and sex matched healthy individuals. The concentration of PRL in the serum was measured by immunoradiometric assays. RESULTS: The PRL serum levels were significantly increased in PsA patients (299.2±28.29 mIU/L) compared to PV only patients (201.4.2±11.72 mIU/L), P = 0.0003 and healthy individuals (198.2±15.31 mIU/L), P = 0.007. The serum PRL levels in PsA with active disease 336.8±42.50 (mIU/L) were higher than in PV and controls, P < 0.0001 and P = 0.002 respectively. In PV only patients, there was no correlation between PASI and PRL levels. CONCLUSION: Our results showed that PRL serum levels are a marker of active arthritis in PsA and reflects systemic complication rather than local skin activity.
Department of Dermatology Stadt Klinikum Gorlitz Girbingsdorfer Strasse 1 3 Gorlitz Germany
Institute of Rheumatology Na Slupi 4 12850 Prague 2 Czech Republic
Citace poskytuje Crossref.org